MIAMI, Aug. 30, 2023 (GLOBE NEWSWIRE) — Veru Inc. VERU, a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ARDS), today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present…Read More
Veru to Present at the HC Wainwright 25th Annual Global Investment Conference on September 11th 2023 Veru NASDAQVERU
